Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.80
    -0.56 (-0.67%)
     
  • GOLD FUTURES

    2,335.90
    -6.20 (-0.26%)
     
  • DOW

    38,376.01
    -127.68 (-0.33%)
     
  • Bitcoin GBP

    51,972.00
    -1,699.81 (-3.17%)
     
  • CMC Crypto 200

    1,401.50
    -22.60 (-1.59%)
     
  • NASDAQ Composite

    15,657.35
    -39.29 (-0.25%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Regeneron Could Benefit From 'Lackluster' Data Presented By These Rivals

Regeneron Could Benefit From 'Lackluster' Data Presented By These Rivals

Regeneron should benefit after Novartis and Roche presented data for competitors to blockbuster eye drug Eylea.